MannKind (STU:NNFN) Land And Improvements : €0.8 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is MannKind Land And Improvements?

MannKind's land and improvements for the quarter that ended in Mar. 2025 was €0.8 Mil.

MannKind's quarterly land and improvements increased from Sep. 2024 (€0.8 Mil) to Dec. 2024 (€0.8 Mil) but then declined from Dec. 2024 (€0.8 Mil) to Mar. 2025 (€0.8 Mil).

MannKind's annual land and improvements declined from Dec. 2022 (€0.8 Mil) to Dec. 2023 (€0.8 Mil) but then increased from Dec. 2023 (€0.8 Mil) to Dec. 2024 (€0.8 Mil).

MannKind Land And Improvements Historical Data

The historical data trend for MannKind's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Land And Improvements Chart

MannKind Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Land And Improvements

Get a 7-Day Free Trial

0.72

0.77

0.83

0.80

0.84

MannKind Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Land And Improvements	Get a 7-Day Free Trial															0.81	0.81	0.79	0.84	0.81

MannKind Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

MannKind Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (STU:NNFN) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

MNKD:USA NNFN:Germany

Address

1 Casper Street, Danbury, CT, USA, 06810

Website

https://www.mannkindcorp.com

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

MannKind Headlines

No Headlines